Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
How Medical Schools and Teaching Hospitals are Addressing the Opioid Epidemic Thursday, January 28, 2016 2:00 p.m. Capitol Visitor Center: HVC-201 Speaker Biographies Terence R. Flotte, MD, is the Celia and Isaac Haidak Professor in Medical Education, dean of the School of Medicine and provost and executive deputy chancellor of the University of Massachusetts Medical School (UMMS). In these roles, Dr. Flotte serves UMMS as chief academic and administrative officer of the School of Medicine, overseeing all academic activities of the basic and clinical science departments, including education and research for the School of Medicine and the Graduate School of Biomedical Sciences. An internationally known pioneer in human gene therapy, Dr. Flotte is currently leading a research group that is investigating the delivery of therapeutic genes and microRNA with recombinant vectors for genetic diseases, such as genetic emphysema In 1995, he was the first to use rAAV as a vehicle to deliver corrective genes to targeted sites in the body in a study at Johns Hopkins Hospital. Since then, he has conducted several Phase 1 clinical trials for both AAT and cystic fibrosis as well as a Phase 2 clinical trial in AAT with vectors developed in his lab. Flotte has received numerous honors and awards, including the Society for Pediatric Research E. Mead Johnson Award for Outstanding Scientific Contributions and the University of Florida Faculty Research Prize in Clinical Science. He has been elected to the American Academy of Physicians, the American Pediatric Society, the Society for Clinical Investigation, and the Society for Pediatric Research. He now serves on the Liaison Committee on Medical Education and the ASGCT Advisory Council, setting policy and goals for promoting gene therapy research through public education, scientific meetings and scientific committees. He also serves in the Massachusetts Medical Society House of Delegates and was a member of the Governor Charlie Baker’s Opioid Prescription Task Force. Bradley Allen, MD, PhD, FACP, FIDSA, is the Senior Associate Dean for Medical Student Education at Indiana University School of Medicine. Dr. Allen also serves as an Associate Professor of Clinical Medicine in the Division of Infectious Diseases. He previously served as the Vice Chair for Education in the Department of Medicine and as the Chief of Medicine at the Richard L. Roudebush VAMC in Indianapolis. Dr. Allen’s expertise and interests include medical education, primary care in HIV, endovascular infections, skin and soft tissue infection, and high value care. Dr. Allen’s received his Bachelor of Science in Microbiology from the University of Iowa, and attended the University of Iowa College of Medicine, where he received his M.D. as well as his Ph.D. in Microbiology in 1992. His postdoctoral training involved an internship, residency, and a Clinical Investigator Pathway at the Baylor College of Medicine in Houston from 1992-1996. In addition, in 1996, he was Chief Medical Resident at the St. Luke’s Episcopal Hospital in Houston. He was also a Fellow, Infectious Diseases, at the Department of Internal Medicine at the University of Iowa Hospitals & Clinics from 1996 to 1998. His certifications include 1996 Diplomate, American Board of Internal Medicine, which was recertified in 2006, 1999 Diplomate, American Board of Internal Medicine, and Infectious Diseases, which was also recertified in 2009. Dr. Allen’s other appointments and activities include, ACP Indiana Chapter Governor-Elect, American College of Physicians, Fellowship, July 2011; Infectious Diseases Society of America, Fellowship 2014, Maintenance of Certification Committee; and Vice President of the VA Society for Practitioners of Infectious Diseases. Alison Volpe Holmes, MD, MPH, is an associate professor of pediatrics at the Dartmouth Institute and the Geisel School of Medicine at Dartmouth. She is course co-director for the medical school third year pediatric clerkship, and co-director of medical student education in pediatrics. Her academic interests focus on clinical quality improvement, particularly in the newborn nursery, in areas such as breastfeeding, jaundice, circumcision and neonatal abstinence syndrome. In January 2013, Dr. Holmes led a team of Geisel School of Medicine faculty, students, and pediatric staff at the Children’s Hospital at Dartmouth-Hitchcock in developing a newly coordinated and standardized care model for treating both opioid-exposed and Neonatal Abstinence Syndrome-affected newborns. As a result, Dr. Holmes and her team were recipients of the AAMC’s 2014-2015 Clinical Care Innovation Challenge Award, which recognizes an institutions accomplishment in successfully implementing a program or project to advance quality and improve care delivery. Dr. Holmes holds a B.S. in Biology from Haverford College, a M.S. in Genetics from University of Washington, a M.D. from Stanford Medical School, and a M.P.H. from University of Rochester. Atul Grover, MD, PhD, is the Chief Public Policy Officer at the Association of American Medical Colleges (AAMC). As chief public policy officer, Dr. Grover manages the health, educational, scientific, and other policies developed by the AAMC. He works with AAMC leadership to coordinate organizational strategy and external relationships to advance those policies and to carry out its mission of advancing the health of the public. He also leads the association's advocacy efforts, leveraging the government relations and communications teams to advance the policy goals of the academic medicine community. Dr. Grover joined the AAMC as associate director for the Center for Workforce Studies in 2005, where he managed research activity and directed externally funded workforce studies. He became a director of government relations and health care affairs in 2007. Prior to joining the AAMC, Dr. Grover was a senior consultant in health care finance and applied economics for The Lewin Group, Inc., from 2003 to 2005. He came to the consulting firm after serving with the U.S. Public Health Service, Health Resources and Service Administration (HRSA). From 2001 until 2003, Dr. Grover worked as a chief medical officer for HRSA's National Center for Health Workforce Analysis, and as a medical officer for the children's hospital graduate medical education program. Trained as a general internist, Dr. Grover holds faculty appointments at the George Washington University (GWU) School of Medicine and Health Sciences, and the Johns Hopkins University Bloomberg School of Public Health, where he obtained his PhD in health and public policy. He received his MD from GWU School of Medicine and Health Sciences in 1995, and completed his residency in internal medicine and primary care at the University of California at San Francisco.